Montreal research team developing medication to combat Ebola
June 05, 2026
June 05, 2026
A group of Montreal researchers is making progress towards developing a medication for Ebola, as well as addressing future potential pandemics.
The team at the Montreal Clinical Research Institute (IRCM) says it is working on a new “antiviral discovered in plants” that is showing promise.
The scientific team is led by Dr. Michel Chrétien and Dr. Majambu Mbikay with the IRCM’s Functional Endoproteolysis Laboratory, who “identified a new family of natural molecules with strong antiviral activity, notably against the Ebola virus and SARS‑CoV‑2, the virus responsible for COVID‑19.”
If successful, the medication could be taken to prevent people from contracting Ebola, as well as help those already infected.
“We are still working, and this one drug is particularly promising,” said Mbikay. “It’s a candidate drug, but we can’t say for sure [if] it is a drug that can be used in humans. That will come later on, but all the signs, all the indications are that it is probably a good one.”
Mainstream NewsBed Bug Infestation Forces Closure of Fort Simpson Schools
Two schools in Fort Simpson, N.W.T., will close starting Monday due to a bed bug infestation, with no confirmed reopening date.
Mainstream NewsThe Complex History of Bible Translations in Greenland and Labrador
Early Christian missionaries in Greenland and Labrador relied on Inuit converts to translate the Bible, revealing a complex interplay of cultural exchange and religious adaptation.
Mainstream NewsInuit-Led Pirutsiagutiit Program Replaces Child First Initiative
Federal government transfers $575M in child health and social support funding to Inuit organizations, ending uncertainty over previous program.
Mainstream NewsWhitehorse Students Engage With Canadian Astronauts Aboard the ISS
Students from Whitehorse schools connected with Canadian astronauts Jenni Gibbons and Joshua Kutryk, gaining insights into space exploration and inspiring future careers in science.